Sign in
Not yet taking people in United StatesPhase 1

Cannabis and Opioid Use Disorder, Study 2

Key facts

Who runs it
University of Kentucky
Where
Lexington, United StatesSee the site
Trial code
Status
Not yet recruiting
Phase
Phase 1
People taking part
100 people, planned
Starts
30 Nov 2026
Expected to end
30 Jan 2030
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Inhaled Cannabis
  • Intranasal Opioid
Record updated
9 October 2026

Who can take part

Age
18 years to 55 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Participants with moderate to severe opioid use disorder

Who cannot take part

  • Individuals who do not use opioids or do not experience opioid withdrawal when they stop using opioids

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 55 years old?

Where in United States

  • University of KentuckyLexington, United StatesContact: Paul NuzzoNot yet recruiting

About the trial

What the trial wants to find out

This inpatient study enrolls healthy individuals who have opioid use disorder. Participants live at the University of Kentucky Hospital for approx. 6 weeks. During this time, we will examine how repeated doses of oral cannabis and acute doses of oral and inhaled cannabis 1) modify the intensity and time course of opioid withdrawal, 2) modify the effects of intranasal opioid administration and 3) impact the safety of opioid administration.

The 2 groups in the trial

  • Oral cannabis (placebo)Placebo, for comparison

    Participants will receive placebo oral cannnabis

    Treatment: Inhaled Cannabis and Intranasal Opioid

  • Oral cannabis (active)Treatment being tested

    Participants will receive active oral cannabis

    Treatment: Inhaled Cannabis and Intranasal Opioid

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT07661446, who can take part
Record updated
9 October 2026